Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Richard B. Hayes(National Cancer Institute), Douglas Reding(Marshfield Clinic), William Kopp(Science Applications International Corporation (United States)), Amy F. Subar(National Cancer Institute), Narayan Bhat(National Cancer Institute), Nathaniel Rothman(National Cancer Institute), Neil E. Caporaso(National Cancer Institute), Regina G. Ziegler(National Cancer Institute), Christine Cole Johnson(Henry Ford Health System), Joel L. Weissfeld(UPMC Hillman Cancer Center), Robert N. Hoover(National Cancer Institute), Patricia Hartge(National Cancer Institute), Cindy Palace(Westat (United States)), John K. Gohagan(National Cancer Institute)
Controlled Clinical Trials
December 1, 2000
Cited by 168

Abstract


Related Papers

No related papers found

Powered by citation graph analysis